Immediate Impact
4 standout
Citing Papers
Exploring treatment options in cancer: tumor treatment strategies
2024 Standout
Epigenetic modification of m6A regulator proteins in cancer
2023 Standout
Works of Moyar Ge being referenced
Abstract 3191: FT516, an off-the-shelf engineered NK cell therapeutic product for universal anti-tumor targeting strategy in combination with monoclonal antibodies
2019
Abstract 3576: FT500, an off-the-shelf NK cell cancer immunotherapy derived from a master pluripotent cell line, enhances T-cell activation and recruitment to overcome checkpoint blockade resistance
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Moyar Ge | 10 | 13 | 5 | 6 | 6 | 28 | |
| Patrick Tomboc | 7 | 6 | 7 | 2 | 5 | 24 | |
| Gillian Q. Horn | 16 | 13 | 4 | 6 | 37 | ||
| Maria Concetta Fargnoli | 13 | 18 | 4 | 8 | 33 | ||
| Chuan Gu | 17 | 12 | 3 | 4 | 28 | ||
| Neilesh B. Parikh | 15 | 13 | 7 | 8 | 25 | ||
| Paweł Bury | 19 | 12 | 5 | 6 | 33 | ||
| Jörg Martens | 9 | 6 | 4 | 6 | 27 | ||
| Xiangyu Fang | 7 | 20 | 6 | 7 | 32 | ||
| Helga Kraxner | 8 | 5 | 12 | 1 | 6 | 33 | |
| Julia E. Rudolph | 6 | 6 | 10 | 2 | 7 | 22 |
All Works
Loading papers...